MARKET

ACONW

ACONW

ACLARION INC
NASDAQ
0.0405
+0.0064
+18.73%
Closed 10:19 03/27 EDT
OPEN
0.0405
PREV CLOSE
0.0341
HIGH
0.0405
LOW
0.0405
VOLUME
237
TURNOVER
--
52 WEEK HIGH
0.2333
52 WEEK LOW
0.0214
MARKET CAP
--
P/E (TTM)
-0.0030
1D
5D
1M
3M
1Y
5Y
1D
Echo Lake Capital urges Aclarion shareholders to oust director David Neal after 99% stock decline
Reuters · 5d ago
Weekly Report: what happened at ACONW last week (0316-0320)?
Weekly Report · 6d ago
Aclarion adopts 1-year stockholder rights plan with USD 14 exercise price
Reuters · 03/19 20:16
Aclarion board adopts one-year stockholder rights plan
Reuters · 03/19 13:26
ACLARION INC - RIGHTS PLAN EXPIRES MARCH 18, 2027 UNLESS EARLIER REDEEMED, EXCHANGED, OR TERMINATED
Reuters · 03/19 13:25
Aclarion Inc. Announces Availability of CEO Shareholder Letter
Reuters · 03/19 10:00
Aclarion reports 114% year-over-year increase in Q4 2025 Nociscan scan volumes
Reuters · 03/19 09:48
Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan
Barchart · 03/19 08:25
More
About ACONW
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Webull offers Aclarion Inc stock information, including NASDAQ: ACONW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACONW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACONW stock methods without spending real money on the virtual paper trading platform.